UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:PPARG-CRYBA4 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: PPARG-CRYBA4 | FusionPDB ID: 67349 | FusionGDB2.0 ID: 67349 | Hgene | Tgene | Gene symbol | PPARG | CRYBA4 | Gene ID | 5468 | 1413 |
Gene name | peroxisome proliferator activated receptor gamma | crystallin beta A4 | |
Synonyms | CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma | CTRCT23|CYRBA4|MCOPCT4 | |
Cytomap | 3p25.2 | 22q12.1 | |
Type of gene | protein-coding | protein-coding | |
Description | peroxisome proliferator-activated receptor gammaPPAR-gammanuclear receptor subfamily 1 group C member 3peroxisome proliferator-activated nuclear receptor gamma variant 1 | beta-crystallin A4beta crystallin A4 chain transcript PSbeta crystallin alpha 4 chainbeta-A4 crystallincrystallin, beta polypeptide A4eye lens structural protein | |
Modification date | 20200329 | 20200328 | |
UniProtAcc | P37231 | P53673 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000287820, ENST00000309576, ENST00000397000, ENST00000397010, ENST00000397012, ENST00000397015, ENST00000397026, ENST00000539812, | ENST00000466315, ENST00000354760, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 7 X 9 X 5=315 | 3 X 3 X 3=27 |
# samples | 13 | 3 | |
** MAII score | log2(13/315*10)=-1.27684020535882 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: PPARG [Title/Abstract] AND CRYBA4 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | PPARG(12422990)-CRYBA4(27019198), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | PPARG-CRYBA4 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. PPARG-CRYBA4 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. PPARG-CRYBA4 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. PPARG-CRYBA4 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | PPARG | GO:0000122 | negative regulation of transcription by RNA polymerase II | 12700342 |
Hgene | PPARG | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 18293083 |
Hgene | PPARG | GO:0007165 | signal transduction | 9568716 |
Hgene | PPARG | GO:0010742 | macrophage derived foam cell differentiation | 26504087 |
Hgene | PPARG | GO:0010745 | negative regulation of macrophage derived foam cell differentiation | 19114110 |
Hgene | PPARG | GO:0010871 | negative regulation of receptor biosynthetic process | 12700342 |
Hgene | PPARG | GO:0010887 | negative regulation of cholesterol storage | 19114110 |
Hgene | PPARG | GO:0010891 | negative regulation of sequestering of triglyceride | 12700342 |
Hgene | PPARG | GO:0016525 | negative regulation of angiogenesis | 28566713 |
Hgene | PPARG | GO:0030224 | monocyte differentiation | 9568716 |
Hgene | PPARG | GO:0032526 | response to retinoic acid | 16239304 |
Hgene | PPARG | GO:0042953 | lipoprotein transport | 9568716 |
Hgene | PPARG | GO:0043537 | negative regulation of blood vessel endothelial cell migration | 28566713 |
Hgene | PPARG | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process | 9568716 |
Hgene | PPARG | GO:0045944 | positive regulation of transcription by RNA polymerase II | 9568715|12700342|16239304|17611579 |
Hgene | PPARG | GO:0048469 | cell maturation | 9568716 |
Hgene | PPARG | GO:0048662 | negative regulation of smooth muscle cell proliferation | 20622039 |
Hgene | PPARG | GO:0051091 | positive regulation of DNA-binding transcription factor activity | 18293083 |
Hgene | PPARG | GO:0061614 | pri-miRNA transcription by RNA polymerase II | 28566713 |
Hgene | PPARG | GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 9568716 |
Hgene | PPARG | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation | 28522568 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BLCA | TCGA-HQ-A2OE-01A | PPARG | chr3 | 12422990 | + | CRYBA4 | chr22 | 27019198 | + |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000397010 | PPARG | chr3 | 12422990 | + | ENST00000354760 | CRYBA4 | chr22 | 27019198 | + | 1517 | 780 | 1358 | 369 | 329 |
ENST00000309576 | PPARG | chr3 | 12422990 | + | ENST00000354760 | CRYBA4 | chr22 | 27019198 | + | 1370 | 633 | 1211 | 222 | 329 |
ENST00000397015 | PPARG | chr3 | 12422990 | + | ENST00000354760 | CRYBA4 | chr22 | 27019198 | + | 1255 | 518 | 122 | 1069 | 315 |
ENST00000397012 | PPARG | chr3 | 12422990 | + | ENST00000354760 | CRYBA4 | chr22 | 27019198 | + | 1506 | 769 | 1347 | 358 | 329 |
ENST00000397026 | PPARG | chr3 | 12422990 | + | ENST00000354760 | CRYBA4 | chr22 | 27019198 | + | 1534 | 797 | 1375 | 395 | 326 |
ENST00000397000 | PPARG | chr3 | 12422990 | + | ENST00000354760 | CRYBA4 | chr22 | 27019198 | + | 1201 | 464 | 68 | 1015 | 315 |
ENST00000539812 | PPARG | chr3 | 12422990 | + | ENST00000354760 | CRYBA4 | chr22 | 27019198 | + | 1201 | 464 | 68 | 1015 | 315 |
ENST00000287820 | PPARG | chr3 | 12422990 | + | ENST00000354760 | CRYBA4 | chr22 | 27019198 | + | 1338 | 601 | 121 | 1152 | 343 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000397010 | ENST00000354760 | PPARG | chr3 | 12422990 | + | CRYBA4 | chr22 | 27019198 | + | 0.010919459 | 0.98908055 |
ENST00000309576 | ENST00000354760 | PPARG | chr3 | 12422990 | + | CRYBA4 | chr22 | 27019198 | + | 0.009764364 | 0.9902356 |
ENST00000397015 | ENST00000354760 | PPARG | chr3 | 12422990 | + | CRYBA4 | chr22 | 27019198 | + | 0.009794493 | 0.99020547 |
ENST00000397012 | ENST00000354760 | PPARG | chr3 | 12422990 | + | CRYBA4 | chr22 | 27019198 | + | 0.005357375 | 0.9946426 |
ENST00000397026 | ENST00000354760 | PPARG | chr3 | 12422990 | + | CRYBA4 | chr22 | 27019198 | + | 0.003373044 | 0.996627 |
ENST00000397000 | ENST00000354760 | PPARG | chr3 | 12422990 | + | CRYBA4 | chr22 | 27019198 | + | 0.009976292 | 0.9900238 |
ENST00000539812 | ENST00000354760 | PPARG | chr3 | 12422990 | + | CRYBA4 | chr22 | 27019198 | + | 0.009976292 | 0.9900238 |
ENST00000287820 | ENST00000354760 | PPARG | chr3 | 12422990 | + | CRYBA4 | chr22 | 27019198 | + | 0.003349697 | 0.9966503 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >67349_67349_1_PPARG-CRYBA4_PPARG_chr3_12422990_ENST00000287820_CRYBA4_chr22_27019198_ENST00000354760_length(amino acids)=343AA_BP=160 MGETLGDSPIDPESDSFTDTLSANISQEMTMVDTEMPFWPTNFGISSVDLSVMEDHSHSFDIKPFTTVDFSSISTPHYEDIPFTRTDPVV ADYKYDLKLQEYQSAIKVEPASPPYYSEKTQLYNKPHEEPSNSLMAIECRVCGDKASGFHYGVHACEGCKMVVWDEDGFQGRRHEFTAEC PSVLELGFETVRSLKVLSGAWVGFEHAGFQGQQYILERGEYPSWDAWGGNTAYPAERLTSFRPAACANHRDSRLTIFEQENFLGKKGELS -------------------------------------------------------------- >67349_67349_2_PPARG-CRYBA4_PPARG_chr3_12422990_ENST00000309576_CRYBA4_chr22_27019198_ENST00000354760_length(amino acids)=329AA_BP=0 MRSSVPHPCSLLDPADALHLEGRGMRAPLPEMFVVTGMVIAFQHILKSSVARKLGANPGPRVDVEGPYFIAFPSHGLEGRIVIAQLSFLA QEVLLLEDCQPRVTVVSTGRRPEGGEPLGGVGRVAAPGIPAWIFASFQNVLLPLEASMLKAHPRSTQHFQRSHSLEAKLQHAGALGRELV PPALEAVLIPHHHLASFTSMNSIVKSRSFISTDTTFNCHEGVGRLFMRLIVELSLLRIIRWRCRLHFDCTLVLLKFQVILVICNHWICSC -------------------------------------------------------------- >67349_67349_3_PPARG-CRYBA4_PPARG_chr3_12422990_ENST00000397000_CRYBA4_chr22_27019198_ENST00000354760_length(amino acids)=315AA_BP=132 MTMVDTEMPFWPTNFGISSVDLSVMEDHSHSFDIKPFTTVDFSSISTPHYEDIPFTRTDPVVADYKYDLKLQEYQSAIKVEPASPPYYSE KTQLYNKPHEEPSNSLMAIECRVCGDKASGFHYGVHACEGCKMVVWDEDGFQGRRHEFTAECPSVLELGFETVRSLKVLSGAWVGFEHAG FQGQQYILERGEYPSWDAWGGNTAYPAERLTSFRPAACANHRDSRLTIFEQENFLGKKGELSDDYPSLQAMGWEGNEVGSFHVHSGAWVC -------------------------------------------------------------- >67349_67349_4_PPARG-CRYBA4_PPARG_chr3_12422990_ENST00000397010_CRYBA4_chr22_27019198_ENST00000354760_length(amino acids)=329AA_BP=0 MRSSVPHPCSLLDPADALHLEGRGMRAPLPEMFVVTGMVIAFQHILKSSVARKLGANPGPRVDVEGPYFIAFPSHGLEGRIVIAQLSFLA QEVLLLEDCQPRVTVVSTGRRPEGGEPLGGVGRVAAPGIPAWIFASFQNVLLPLEASMLKAHPRSTQHFQRSHSLEAKLQHAGALGRELV PPALEAVLIPHHHLASFTSMNSIVKSRSFISTDTTFNCHEGVGRLFMRLIVELSLLRIIRWRCRLHFDCTLVLLKFQVILVICNHWICSC -------------------------------------------------------------- >67349_67349_5_PPARG-CRYBA4_PPARG_chr3_12422990_ENST00000397012_CRYBA4_chr22_27019198_ENST00000354760_length(amino acids)=329AA_BP=0 MRSSVPHPCSLLDPADALHLEGRGMRAPLPEMFVVTGMVIAFQHILKSSVARKLGANPGPRVDVEGPYFIAFPSHGLEGRIVIAQLSFLA QEVLLLEDCQPRVTVVSTGRRPEGGEPLGGVGRVAAPGIPAWIFASFQNVLLPLEASMLKAHPRSTQHFQRSHSLEAKLQHAGALGRELV PPALEAVLIPHHHLASFTSMNSIVKSRSFISTDTTFNCHEGVGRLFMRLIVELSLLRIIRWRCRLHFDCTLVLLKFQVILVICNHWICSC -------------------------------------------------------------- >67349_67349_6_PPARG-CRYBA4_PPARG_chr3_12422990_ENST00000397015_CRYBA4_chr22_27019198_ENST00000354760_length(amino acids)=315AA_BP=132 MTMVDTEMPFWPTNFGISSVDLSVMEDHSHSFDIKPFTTVDFSSISTPHYEDIPFTRTDPVVADYKYDLKLQEYQSAIKVEPASPPYYSE KTQLYNKPHEEPSNSLMAIECRVCGDKASGFHYGVHACEGCKMVVWDEDGFQGRRHEFTAECPSVLELGFETVRSLKVLSGAWVGFEHAG FQGQQYILERGEYPSWDAWGGNTAYPAERLTSFRPAACANHRDSRLTIFEQENFLGKKGELSDDYPSLQAMGWEGNEVGSFHVHSGAWVC -------------------------------------------------------------- >67349_67349_7_PPARG-CRYBA4_PPARG_chr3_12422990_ENST00000397026_CRYBA4_chr22_27019198_ENST00000354760_length(amino acids)=326AA_BP=0 MRSSVPHPCSLLDPADALHLEGRGMRAPLPEMFVVTGMVIAFQHILKSSVARKLGANPGPRVDVEGPYFIAFPSHGLEGRIVIAQLSFLA QEVLLLEDCQPRVTVVSTGRRPEGGEPLGGVGRVAAPGIPAWIFASFQNVLLPLEASMLKAHPRSTQHFQRSHSLEAKLQHAGALGRELV PPALEAVLIPHHHLASFTSMNSIVKSRSFISTDTTFNCHEGVGRLFMRLIVELSLLRIIRWRCRLHFDCTLVLLKFQVILVICNHWICSC -------------------------------------------------------------- >67349_67349_8_PPARG-CRYBA4_PPARG_chr3_12422990_ENST00000539812_CRYBA4_chr22_27019198_ENST00000354760_length(amino acids)=315AA_BP=132 MTMVDTEMPFWPTNFGISSVDLSVMEDHSHSFDIKPFTTVDFSSISTPHYEDIPFTRTDPVVADYKYDLKLQEYQSAIKVEPASPPYYSE KTQLYNKPHEEPSNSLMAIECRVCGDKASGFHYGVHACEGCKMVVWDEDGFQGRRHEFTAECPSVLELGFETVRSLKVLSGAWVGFEHAG FQGQQYILERGEYPSWDAWGGNTAYPAERLTSFRPAACANHRDSRLTIFEQENFLGKKGELSDDYPSLQAMGWEGNEVGSFHVHSGAWVC -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr3:12422990/chr22:27019198) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
PPARG | CRYBA4 |
FUNCTION: Nuclear receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the nuclear receptor binds to DNA specific PPAR response elements (PPRE) and modulates the transcription of its target genes, such as acyl-CoA oxidase. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis. ARF6 acts as a key regulator of the tissue-specific adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut homeostasis by suppressing NF-kappa-B-mediated proinflammatory responses. Plays a role in the regulation of cardiovascular circadian rhythms by regulating the transcription of ARNTL/BMAL1 in the blood vessels (By similarity). {ECO:0000250|UniProtKB:P37238, ECO:0000269|PubMed:16150867, ECO:0000269|PubMed:20829347, ECO:0000269|PubMed:23525231, ECO:0000269|PubMed:9065481}.; FUNCTION: (Microbial infection) Upon treatment with M.tuberculosis or its lipoprotein LpqH, phosphorylation of MAPK p38 and IL-6 production are modulated, probably via this protein. {ECO:0000269|PubMed:25504154}. | FUNCTION: Crystallins are the dominant structural components of the vertebrate eye lens. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000287820 | + | 3 | 7 | 139_159 | 160.0 | 506.0 | Zinc finger | NR C4-type |
Tgene | CRYBA4 | chr3:12422990 | chr22:27019198 | ENST00000354760 | 1 | 6 | 105_146 | 13.0 | 197.0 | Domain | Beta/gamma crystallin 'Greek key' 3 | |
Tgene | CRYBA4 | chr3:12422990 | chr22:27019198 | ENST00000354760 | 1 | 6 | 12_51 | 13.0 | 197.0 | Domain | Beta/gamma crystallin 'Greek key' 1 | |
Tgene | CRYBA4 | chr3:12422990 | chr22:27019198 | ENST00000354760 | 1 | 6 | 147_195 | 13.0 | 197.0 | Domain | Beta/gamma crystallin 'Greek key' 4 | |
Tgene | CRYBA4 | chr3:12422990 | chr22:27019198 | ENST00000354760 | 1 | 6 | 52_98 | 13.0 | 197.0 | Domain | Beta/gamma crystallin 'Greek key' 2 | |
Tgene | CRYBA4 | chr3:12422990 | chr22:27019198 | ENST00000354760 | 1 | 6 | 99_104 | 13.0 | 197.0 | Region | Note=Connecting peptide |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000287820 | + | 3 | 7 | 136_210 | 160.0 | 506.0 | DNA binding | Nuclear receptor |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000309576 | + | 4 | 8 | 136_210 | 132.0 | 478.0 | DNA binding | Nuclear receptor |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000397010 | + | 4 | 8 | 136_210 | 132.0 | 478.0 | DNA binding | Nuclear receptor |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000397012 | + | 4 | 8 | 136_210 | 132.0 | 478.0 | DNA binding | Nuclear receptor |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000397015 | + | 3 | 7 | 136_210 | 132.0 | 478.0 | DNA binding | Nuclear receptor |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000287820 | + | 3 | 7 | 238_503 | 160.0 | 506.0 | Domain | NR LBD |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000309576 | + | 4 | 8 | 238_503 | 132.0 | 478.0 | Domain | NR LBD |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000397010 | + | 4 | 8 | 238_503 | 132.0 | 478.0 | Domain | NR LBD |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000397012 | + | 4 | 8 | 238_503 | 132.0 | 478.0 | Domain | NR LBD |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000397015 | + | 3 | 7 | 238_503 | 132.0 | 478.0 | Domain | NR LBD |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000287820 | + | 3 | 7 | 495_503 | 160.0 | 506.0 | Motif | 9aaTAD |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000309576 | + | 4 | 8 | 495_503 | 132.0 | 478.0 | Motif | 9aaTAD |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000397010 | + | 4 | 8 | 495_503 | 132.0 | 478.0 | Motif | 9aaTAD |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000397012 | + | 4 | 8 | 495_503 | 132.0 | 478.0 | Motif | 9aaTAD |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000397015 | + | 3 | 7 | 495_503 | 132.0 | 478.0 | Motif | 9aaTAD |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000287820 | + | 3 | 7 | 176_198 | 160.0 | 506.0 | Zinc finger | NR C4-type |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000309576 | + | 4 | 8 | 139_159 | 132.0 | 478.0 | Zinc finger | NR C4-type |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000309576 | + | 4 | 8 | 176_198 | 132.0 | 478.0 | Zinc finger | NR C4-type |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000397010 | + | 4 | 8 | 139_159 | 132.0 | 478.0 | Zinc finger | NR C4-type |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000397010 | + | 4 | 8 | 176_198 | 132.0 | 478.0 | Zinc finger | NR C4-type |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000397012 | + | 4 | 8 | 139_159 | 132.0 | 478.0 | Zinc finger | NR C4-type |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000397012 | + | 4 | 8 | 176_198 | 132.0 | 478.0 | Zinc finger | NR C4-type |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000397015 | + | 3 | 7 | 139_159 | 132.0 | 478.0 | Zinc finger | NR C4-type |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000397015 | + | 3 | 7 | 176_198 | 132.0 | 478.0 | Zinc finger | NR C4-type |
Tgene | CRYBA4 | chr3:12422990 | chr22:27019198 | ENST00000354760 | 1 | 6 | 2_11 | 13.0 | 197.0 | Region | Note=N-terminal arm |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
PPARG | NCOA4, GADD45G, Gadd45b, DNTTIP2, PPARGC1A, HDAC3, HDAC4, RB1, EP300, EDF1, FABP1, NR0B2, SVIL, NRIP1, POU1F1, CREBBP, RXRA, MED24, MSX2, PML, ZBTB5, NR2E3, MAFF, ZBTB20, ZBTB3, ZNF496, ZBTB9, ZSCAN1, PIAS1, NCOR1, NCOR2, HMGA1, SP1, TFAP2A, CEBPB, MED1, ZNHIT3, TRIP4, JMJD1C, NFKBIB, SERPINH1, NCOA1, TRIM24, NCOA2, NCOA3, GRIP1, KAT5, LRIF1, HDAC1, MECP2, EZH2, NCOA6, NR0B1, COPS5, FHOD1, KIF1A, RXRB, ROBO4, KLF4, KDM4C, TNP1, KCTD13, RAD54L2, ANP32A, APP, RELA, UBC, CDC34, JAZF1, MED14, BCAS2, NEDD4, Rxra, SMARCD3, SMARCA4, CDK5, MIF4GD, USP7, ALOX15B, NR3C1, MUC1, NSD1, PAXIP1, ASH2L, RBBP5, PRKAA1, PRKAA2, CTNNB1, SFPQ, NR4A1, NR4A2, JUN, NFE2L3, PHB2, STAT5A, VDR, RXRG, MAP2K1, CAV1, SMAD3, PDIA2, PPM1B, Foxo1, daf-12, XRCC6, XRCC5, MAPK1, RANBP3, XPO1, Ncor1, JUND, LMO4, RFX5, CIITA, TCF4, NFKB1, PPARG, PRKCA, PIN1, STAT6, IKBKB, KAT2A, KIF11, CEP350, UBE2I, KLF5, IGFBP3, EGFR, MDM2, YWHAB, YWHAG, PPARGC1B, STAT1, STUB1, Pparg, FLYWCH2, PAK4, TNIP2, MFHAS1, TP53, VIMP, SELK, SIRT1, Smurf1, HSPA8, BAG2, RPS3, HNRNPM, HNRNPH1, TUFM, CCT3, DDX17, HSPA1B, TCP1, VCP, BAG5, DHX9, PGAM1, ATP5O, PGD, RUVBL1, RUVBL2, HSPA9, HSPA5, LCP1, CCT8, PPEF2, LGALS7, MRE11A, TOP2B, NAT10, TLN1, RPA2, LIG3, VPS29, RPS8, PBRM1, ZC3HAV1, KHSRP, GIGYF2, MCM7, HSPA6, TRIM28, HEATR1, LRPPRC, RPL10A, SAFB2, SF3B3, NOP14, RPL7A, RPL9, GTF2I, DNAJC7, EFTUD2, DDX18, SH3BGRL, DDX58, HNRNPK, DNAJA3, NUP93, NBN, PSMD11, ILF3, RAD50, SMARCA5, U2SURP, RSL1D1, PSMC1, NOP2, DDX52, UTP14A, ARPC2, ILF2, RPS4X, GTPBP4, H2AFY, DSP, NOP58, POF1B, LGALS3, GNL3, MSN, S100A9, HSP90AA1, DNAJA1, ARPC5, POLR1C, RRP9, UBR5, ATMIN, PROX1, SRSF1, NR1H3, NR1H2, Ppargc1a, MAPK9, ADCY4, GATA5, RARA, TRIM37, ESRRA, TRIM63, VHL, TRIM13, C6orf106, TRIM27, TRIB3, HDAC9, KMT2D, KDM6A, HIVEP1, SMARCA2, KMT2C, KAT2B, SMARCC1, SMARCD1, ZNF536, TBL1X, TADA2A, TADA3, NDUFA8, MLLT6, GPS2, BCL7A, ARID2, ZZZ3, ARID1B, KDM2B, DPF1, DPF2, TBL1XR1, CSRP2BP, BRD9, BRD7, MBIP, GLTSCR1, TRPS1, |
![]() |
Gene | STRING network |
PPARG | ![]() |
CRYBA4 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000287820 | + | 3 | 7 | 205_280 | 160.0 | 506.0 | FAM120B |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000309576 | + | 4 | 8 | 205_280 | 132.0 | 478.0 | FAM120B |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000397010 | + | 4 | 8 | 205_280 | 132.0 | 478.0 | FAM120B |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000397012 | + | 4 | 8 | 205_280 | 132.0 | 478.0 | FAM120B |
Hgene | PPARG | chr3:12422990 | chr22:27019198 | ENST00000397015 | + | 3 | 7 | 205_280 | 132.0 | 478.0 | FAM120B |
Top |
Related Drugs to PPARG-CRYBA4 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to PPARG-CRYBA4 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | PPARG | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 6 | CTD_human;GENOMICS_ENGLAND |
Hgene | PPARG | C0238463 | Papillary thyroid carcinoma | 4 | ORPHANET |
Hgene | PPARG | C0002152 | Alloxan Diabetes | 3 | CTD_human |
Hgene | PPARG | C0002395 | Alzheimer's Disease | 3 | CTD_human |
Hgene | PPARG | C0011265 | Presenile dementia | 3 | CTD_human |
Hgene | PPARG | C0011853 | Diabetes Mellitus, Experimental | 3 | CTD_human |
Hgene | PPARG | C0020538 | Hypertensive disease | 3 | CTD_human |
Hgene | PPARG | C0021655 | Insulin Resistance | 3 | CTD_human |
Hgene | PPARG | C0022660 | Kidney Failure, Acute | 3 | CTD_human |
Hgene | PPARG | C0028754 | Obesity | 3 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | PPARG | C0035126 | Reperfusion Injury | 3 | CTD_human |
Hgene | PPARG | C0038433 | Streptozotocin Diabetes | 3 | CTD_human |
Hgene | PPARG | C0276496 | Familial Alzheimer Disease (FAD) | 3 | CTD_human |
Hgene | PPARG | C0494463 | Alzheimer Disease, Late Onset | 3 | CTD_human |
Hgene | PPARG | C0546126 | Acute Confusional Senile Dementia | 3 | CTD_human |
Hgene | PPARG | C0750900 | Alzheimer's Disease, Focal Onset | 3 | CTD_human |
Hgene | PPARG | C0750901 | Alzheimer Disease, Early Onset | 3 | CTD_human |
Hgene | PPARG | C0920563 | Insulin Sensitivity | 3 | CTD_human |
Hgene | PPARG | C1565662 | Acute Kidney Insufficiency | 3 | CTD_human |
Hgene | PPARG | C1720861 | Familial Partial Lipodystrophy, Type 3 | 3 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | PPARG | C2609414 | Acute kidney injury | 3 | CTD_human |
Hgene | PPARG | C0021368 | Inflammation | 2 | CTD_human |
Hgene | PPARG | C0022116 | Ischemia | 2 | CTD_human |
Hgene | PPARG | C0024623 | Malignant neoplasm of stomach | 2 | CTD_human |
Hgene | PPARG | C0025202 | melanoma | 2 | CTD_human |
Hgene | PPARG | C0030297 | Pancreatic Neoplasm | 2 | CTD_human |
Hgene | PPARG | C0038356 | Stomach Neoplasms | 2 | CTD_human |
Hgene | PPARG | C0346647 | Malignant neoplasm of pancreas | 2 | CTD_human |
Hgene | PPARG | C1708349 | Hereditary Diffuse Gastric Cancer | 2 | CTD_human |
Hgene | PPARG | C0001418 | Adenocarcinoma | 1 | CTD_human |
Hgene | PPARG | C0004153 | Atherosclerosis | 1 | CTD_human |
Hgene | PPARG | C0004763 | Barrett Esophagus | 1 | CTD_human |
Hgene | PPARG | C0007102 | Malignant tumor of colon | 1 | CTD_human;UNIPROT |
Hgene | PPARG | C0009375 | Colonic Neoplasms | 1 | CTD_human |
Hgene | PPARG | C0009402 | Colorectal Carcinoma | 1 | CTD_human |
Hgene | PPARG | C0009404 | Colorectal Neoplasms | 1 | CTD_human |
Hgene | PPARG | C0010346 | Crohn Disease | 1 | CTD_human |
Hgene | PPARG | C0011849 | Diabetes Mellitus | 1 | CTD_human |
Hgene | PPARG | C0011859 | Lipoatrophic Diabetes Mellitus | 1 | ORPHANET |
Hgene | PPARG | C0011881 | Diabetic Nephropathy | 1 | CTD_human |
Hgene | PPARG | C0017658 | Glomerulonephritis | 1 | CTD_human |
Hgene | PPARG | C0017667 | Nodular glomerulosclerosis | 1 | CTD_human |
Hgene | PPARG | C0018801 | Heart failure | 1 | CTD_human |
Hgene | PPARG | C0018802 | Congestive heart failure | 1 | CTD_human |
Hgene | PPARG | C0023212 | Left-Sided Heart Failure | 1 | CTD_human |
Hgene | PPARG | C0023645 | Lichen planus follicularis | 1 | GENOMICS_ENGLAND |
Hgene | PPARG | C0023794 | Lipoidosis | 1 | CTD_human |
Hgene | PPARG | C0023903 | Liver neoplasms | 1 | CTD_human |
Hgene | PPARG | C0025517 | Metabolic Diseases | 1 | CTD_human |
Hgene | PPARG | C0027746 | Nerve Degeneration | 1 | CTD_human |
Hgene | PPARG | C0029408 | Degenerative polyarthritis | 1 | CTD_human |
Hgene | PPARG | C0030246 | Pustulosis of Palms and Soles | 1 | CTD_human |
Hgene | PPARG | C0030625 | Passive Cutaneous Anaphylaxis | 1 | GENOMICS_ENGLAND |
Hgene | PPARG | C0033860 | Psoriasis | 1 | CTD_human |
Hgene | PPARG | C0035078 | Kidney Failure | 1 | CTD_human |
Hgene | PPARG | C0038525 | Subarachnoid Hemorrhage | 1 | CTD_human |
Hgene | PPARG | C0040136 | Thyroid Neoplasm | 1 | CTD_human |
Hgene | PPARG | C0079772 | T-Cell Lymphoma | 1 | CTD_human |
Hgene | PPARG | C0085278 | Antiphospholipid Syndrome | 1 | CTD_human |
Hgene | PPARG | C0085413 | Polycystic Kidney, Autosomal Dominant | 1 | CTD_human |
Hgene | PPARG | C0086743 | Osteoarthrosis Deformans | 1 | CTD_human |
Hgene | PPARG | C0086873 | Pseudopelade | 1 | GENOMICS_ENGLAND |
Hgene | PPARG | C0151468 | Thyroid Gland Follicular Adenoma | 1 | CTD_human |
Hgene | PPARG | C0156147 | Crohn's disease of large bowel | 1 | CTD_human |
Hgene | PPARG | C0205641 | Adenocarcinoma, Basal Cell | 1 | CTD_human |
Hgene | PPARG | C0205642 | Adenocarcinoma, Oxyphilic | 1 | CTD_human |
Hgene | PPARG | C0205643 | Carcinoma, Cribriform | 1 | CTD_human |
Hgene | PPARG | C0205644 | Carcinoma, Granular Cell | 1 | CTD_human |
Hgene | PPARG | C0205645 | Adenocarcinoma, Tubular | 1 | CTD_human |
Hgene | PPARG | C0206726 | gliosarcoma | 1 | ORPHANET |
Hgene | PPARG | C0221032 | Familial generalized lipodystrophy | 1 | ORPHANET |
Hgene | PPARG | C0221406 | Pituitary-dependent Cushing's disease | 1 | CTD_human |
Hgene | PPARG | C0235527 | Heart Failure, Right-Sided | 1 | CTD_human |
Hgene | PPARG | C0236811 | Chronobiology Disorders | 1 | CTD_human |
Hgene | PPARG | C0242339 | Dyslipidemias | 1 | CTD_human |
Hgene | PPARG | C0242488 | Acute Lung Injury | 1 | CTD_human |
Hgene | PPARG | C0267380 | Crohn's disease of the ileum | 1 | CTD_human |
Hgene | PPARG | C0270192 | Perinatal Subarachnoid Hemorrhage | 1 | CTD_human |
Hgene | PPARG | C0271694 | Familial partial lipodystrophy | 1 | CTD_human |
Hgene | PPARG | C0282548 | Leukostasis | 1 | CTD_human |
Hgene | PPARG | C0334588 | Giant Cell Glioblastoma | 1 | ORPHANET |
Hgene | PPARG | C0345904 | Malignant neoplasm of liver | 1 | CTD_human |
Hgene | PPARG | C0472383 | Subarachnoid Hemorrhage, Spontaneous | 1 | CTD_human |
Hgene | PPARG | C0525045 | Mood Disorders | 1 | PSYGENET |
Hgene | PPARG | C0549473 | Thyroid carcinoma | 1 | CTD_human |
Hgene | PPARG | C0598784 | Dyslipoproteinemias | 1 | CTD_human |
Hgene | PPARG | C0678202 | Regional enteritis | 1 | CTD_human |
Hgene | PPARG | C0751220 | Inappropriate ACTH Secretion Syndrome | 1 | CTD_human |
Hgene | PPARG | C0751530 | Subarachnoid Hemorrhage, Aneurysmal | 1 | CTD_human |
Hgene | PPARG | C0795688 | Subarachnoid Hemorrhage, Intracranial | 1 | CTD_human |
Hgene | PPARG | C0813142 | Circadian Rhythm Disorders | 1 | CTD_human |
Hgene | PPARG | C0887800 | Psychogenic Inversion of Circadian Rhythm | 1 | CTD_human |
Hgene | PPARG | C0887850 | Polycystic Kidney, Type 1 Autosomal Dominant Disease | 1 | CTD_human |
Hgene | PPARG | C0949272 | IIeocolitis | 1 | CTD_human |
Hgene | PPARG | C1258085 | Barrett Epithelium | 1 | CTD_human |
Hgene | PPARG | C1563937 | Atherogenesis | 1 | CTD_human |
Hgene | PPARG | C1565489 | Renal Insufficiency | 1 | CTD_human |
Hgene | PPARG | C1704377 | Bright Disease | 1 | CTD_human |
Hgene | PPARG | C1720859 | Familial Partial Lipodystrophy, Type 1 | 1 | CTD_human |
Hgene | PPARG | C1720860 | Familial Partial Lipodystrophy, Type 2 | 1 | CTD_human |
Hgene | PPARG | C1959583 | Myocardial Failure | 1 | CTD_human |
Hgene | PPARG | C1961112 | Heart Decompensation | 1 | CTD_human |
Hgene | PPARG | C2239176 | Liver carcinoma | 1 | CTD_human |
Hgene | PPARG | C2751306 | Polycystic kidney disease, type 2 | 1 | CTD_human |
Hgene | PPARG | C2931367 | Thyroid cancer, follicular | 1 | CTD_human |
Hgene | PPARG | C2936846 | Scarring alopecia | 1 | GENOMICS_ENGLAND |